1. Le VNH, Hou Y, Bock F, Cursiefen C. Supplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis. Scientific Reports. 2020;10(1). doi: 10.1038/s41598-020-60705-z
2. Le VNH, Wabnig F, Bachmann B, Cursiefen C. Epithelial downgrowth after Descemet membrane endothelial keratoplasty. European Journal of Ophthalmology. 2020;31(2):NP27-NP32. doi: 10.1177/1120672120912413
3. Hayashi T, Schrittenlocher S, Siebelmann S, et al. Risk factors for endothelial cell loss after Descemet membrane endothelial keratoplasty (DMEK). Scientific Reports. 2020;10(1). doi: 10.1038/s41598-020-68023-0
4. Hayashi T, Zhang W, Hos D, et al. Descemet Membrane Endothelial Keratoplasty in Vascularized Eyes: Outcome and Effect on Corneal Neovascularization. Cornea. 2020;40(6):685-689. doi: 10.1097/ICO.0000000000002502
5. Le VNH, Hos D, Hou Y, et al. VEGF TrapR1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis. Translational Vision Science & Technology. 2020;9(11):15. doi: 10.1167/tvst.9.11.15
6. Hos D, Matthaei M, Bock F, et al. Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation. Progress in Retinal and Eye Research. 2019;73:100768. doi: 10.1016/j.preteyeres.2019.07.001
7. Hos D, Le VNH, Hellmich M, et al. Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study. Transplantation Direct. 2019;5(5):e452. doi: 10.1097/TXD.0000000000000894
8. Hung Le VN, Bachmann B, Avgitidou G, Cursiefen C. Treatment of corneal edema secondary to chemical burn by Descemet membrane endothelial keratoplasty (DMEK). Canadian Journal of Ophthalmology. 2019;54(1):e43-e47. doi: 10.1016/j.jcjo.2018.04.010
9. Le VNH, Schneider A, Scholz R, Bock F, Cursiefen C. Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival. Scientific Reports. 2018;8(1). doi: 10.1038/s41598-018-24037-3
10. Hou Y, Le VNH, Clahsen T, Schneider A, Bock F, Cursiefen C. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival. Investigative Opthalmology & Visual Science. 2017;58(13):5862. doi: 10.1167/iovs.17-22904
11. Le VNH, Hou Y, Horstmann J, Bock F, Cursiefen C. Novel Method to Detect Corneal Lymphatic Vessels In Vivo by Intrastromal Injection of Fluorescein. Cornea. 2017;37(2):267-271. doi: 10.1097/ICO.0000000000001444